Manufacture of tumor- and virus-specific T lymphocytes for adoptive cell therapies Journal Article
| Authors: | Wang, X.; Rivière, I. |
| Article Title: | Manufacture of tumor- and virus-specific T lymphocytes for adoptive cell therapies |
| Abstract: | Adoptive transfer of tumor-infiltrating lymphocytes (TILs) and genetically engineered T lymphocytes expressing chimeric antigen receptors (CARs) or conventional alpha/beta T-cell receptors (TCRs), collectively termed adoptive cell therapy (ACT), is an emerging novel strategy to treat cancer patients. Application of ACT has been constrained by the ability to isolate and expand functional tumor-reactive T cells. The transition of ACT from a promising experimental regimen to an established standard of care treatment relies largely on the establishment of safe, efficient, robust and cost-effective cell manufacturing protocols. The manufacture of cellular products under current good manufacturing practices (cGMPs) has a critical role in the process. Herein, we review current manufacturing methods for the large-scale production of clinical-grade TILs, virus-specific and genetically modified CAR or TCR transduced T cells in the context of phase I/II clinical trials as well as the regulatory pathway to get these complex personalized cellular products to the clinic. © 2015 Nature America, Inc. |
| Keywords: | review; nonhuman; t lymphocyte; tumor associated leukocyte; t lymphocyte receptor; dna modification; genetic engineering; lentivirus vector; retrovirus vector; chimeric antigen receptor; adoptive transfer; adoptive immunotherapy; transposon; expression vector; human; priority journal |
| Journal Title: | Cancer Gene Therapy |
| Volume: | 22 |
| Issue: | 2 |
| ISSN: | 0929-1903 |
| Publisher: | Nature Publishing Group |
| Date Published: | 2015-03-01 |
| Start Page: | 85 |
| End Page: | 94 |
| Language: | English |
| DOI: | 10.1038/cgt.2014.81 |
| PROVIDER: | scopus |
| PUBMED: | 25721207 |
| PMCID: | PMC4480367 |
| DOI/URL: | |
| Notes: | Export Date: 2 April 2015 -- Source: Scopus |
Altmetric
Citation Impact
BMJ Impact Analytics
Related MSK Work